The U.S. Food and Drug Administration (FDA) has approved a new drug, tarlatamab (Imdelltra), for treating patients with an advanced and deadly form of lung cancer. Breakthrough Treatment for Small Cell Lung Cancer This approval is particularly significant for those suffering from extensive-stage small cell lung cancer (ES-SCLC) who have exhausted all other treatment options. … Read more
Amylyx Pharmaceuticals, the maker of Relyvrio, a drug intended to treat Lou Gehrig’s disease (amyotrophic lateral sclerosis or ALS), announced on Thursday its decision to pull the medication from the market. This move comes after the drug failed to demonstrate efficacy in a large clinical study, marking a significant setback for ALS patients and advocates. … Read more
Federal regulators have greenlit an expanded application for the weight-loss medication Wegovy, allowing it to be utilized in reducing the risk of stroke, heart attacks, and other severe cardiovascular complications in patients grappling with overweight or obesity, announced the U.S. Food and Drug Administration on Friday. The regulatory decision follows a label change request from … Read more
One Utilizes CRISPR Technology, Offering Hope for Patients Battling the Debilitating Blood Disorder In a historic move, the Food and Drug Administration (FDA) has granted approval for two gene therapies designed to treat sickle cell disease, a painful and hereditary blood disorder predominantly affecting Black individuals in the U.S. These breakthrough treatments, deemed potential cures, … Read more
Breakthrough Treatments Targeting Severe Forms of the Disease Set to Transform Lives In a groundbreaking move, U.S. regulators have granted approval for two gene therapies designed to potentially cure sickle cell disease, a painful and hereditary blood disorder that disproportionately affects Black individuals in the United States. The Food and Drug Administration (FDA) announced on … Read more